RecruitingNANCT06883448

The SUITS Study: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

Sponsor: Erasmus Medical Center

Trial Details

Condition	Pulmonary Fibrosis, Interstitial Lung Disease (ILD)
Intervention	Home monitoring care
Phase	NA
Status	Recruiting
Participants	220
Est. Completion	1 Sept 2027
Last Updated	27 May 2026

Primary Outcome

Patient self-management

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * A multidisciplinary ILD team diagnosis of pulmonary fibrosis according to ATS/ERS/JRS/ALAT guidelines; * Adults (=/\>18 years). Exclusion Criteria: * Patients who are not able to speak, read and/or write in Dutch; * Patients with no access to the internet; * Patients with a life expectancy of less than 1 year as determined by the treating healthcare provider; * Patients who are or have been using a home monitoring program for PF.

Trial Sites

Countries

Netherlands

View Registry Entry

Related Analysis

SUITS Study Opens: Home Monitoring vs Standard Care in Pulmonary Fibrosis — Implementation Trial for Clinicians

The SUITS Study is investigating whether home monitoring can replace half of outpatient visits for pulmonary fibrosis patients. This Dutch implementation trial could transform respiratory care delivery globally.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service